EPO Patent Publication EP4048683A2: Variant Alpha-Amylases

The European Patent Office has published patent application EP4048683A2 concerning variant maltopentaose/maltohexaose-forming alpha-amylases, with Danisco US Inc. listed as the applicant. This publication is part of the EPO's regular bulletin for the C07K classification, related to peptides.

Halogenated Antimicrobial Peptoids Patent EP3962925A1

The European Patent Office published patent application EP3962925A1 on March 11, 2026, concerning Halogenated Antimicrobial Peptoids. The patent application lists Maxwell Biosciences, Inc. as the applicant and details inventors Natalia Molchanova, Havard Jenssen, and Annelise Barron.

Anti-CD45 Antibody Drug Conjugates Patent Application EP3958910A1

The European Patent Office has published patent application EP3958910A1 concerning anti-CD45 antibody drug conjugates and their uses. The application was filed by Regeneron Pharmaceuticals, Inc. and lists multiple inventors. The publication date is March 11, 2026.

ABL Bio Inc. Anti-4-1BB Antibody Patent Publication

The European Patent Office has published patent application EP3887403A1 by ABL Bio Inc. for an anti-4-1BB antibody and its use. This publication relates to intellectual property protection for novel therapeutic agents.

Patent EP3893930A1: Monoclonal Antibodies Against Human Dickkopf3

The European Patent Office has published patent application EP3893930A1 concerning monoclonal antibodies against human Dickkopf3 and their uses. The patent was published on March 11, 2026, with the Board of Regents, The University of Texas System listed as the applicant.

EPO Patent Bulletin: WT1 Peptides for Preventing Polyposis

The European Patent Office has published patent application EP3865146A1 concerning WT1 peptides and analogs for preventing or treating familial adenomatous polyposis and non-hereditary colorectal adenoma. The application lists the International Institute of Cancer Immunology, Inc. as the applicant.

EPO Patent Publication EP4004028A1: Relaxin Analogs

The European Patent Office has published patent application EP4004028A1 concerning relaxin analogs and methods of use, filed by Eli Lilly and Company. This publication provides notice of the patent application's details and designated states.

EPO Patent Publication: Antigen-binding protein constructs

The European Patent Office has published patent application EP3996817A1 concerning antigen-binding protein constructs and their uses, filed by Mythic Therapeutics, Inc. The publication date is March 11, 2026.

Anti-Gal3 antibodies and uses patent EP3918323A2

Anti-Gal3 antibodies and uses patent EP3918323A2

HEYBOT Trademark Application Filed

The USPTO has received an intent-to-use trademark application for the mark HEYBOT, filed on December 3, 2024. The application covers various audio speaker and headphone products. This filing initiates the trademark registration process.